0001929354-23-000014.txt : 20230614
0001929354-23-000014.hdr.sgml : 20230614
20230614161407
ACCESSION NUMBER: 0001929354-23-000014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230612
FILED AS OF DATE: 20230614
DATE AS OF CHANGE: 20230614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Caissa Capital Management ltd.
CENTRAL INDEX KEY: 0001929354
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 231014263
BUSINESS ADDRESS:
STREET 1: PALM GROVE HOUSE
STREET 2: WICKHAMS CAY 1 ROAD TOWN
CITY: TORTOLA
STATE: D8
ZIP: VG1110
BUSINESS PHONE: 00377 99 90 25 95
MAIL ADDRESS:
STREET 1: PALM GROVE HOUSE
STREET 2: WICKHAMS CAY 1 ROAD TOWN
CITY: TORTOLA
STATE: D8
ZIP: VG1110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0407
4
2023-06-12
0
0001534120
Avalo Therapeutics, Inc.
AVTX
0001929354
Caissa Capital Management ltd.
PALM GROVE HOUSE
WICKHAMS CAY 1 ROAD TOWN
TORTOLA
D8
VG1110
VIRGIN ISLANDS, BRITISH
0
0
1
0
0
Common Stock
2023-06-12
4
P
0
2149
4.3352
A
1402790
I
See Footnote (1)
Common Stock
2023-06-13
4
P
0
8750
3.8216
A
1411540
I
See Footnote (1)
Common Stock
2023-06-14
4
P
0
6000
3.479
A
1417540
I
See Footnote (1)
Common Stock
182300
D
Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.125 to $4.47, inclusive.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7 to $3.83, inclusive.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.245 to $3.55, inclusive.
These shares are directly owned by Mr. Golestaneh in his personal capacity.
Cambyz Golestaneh, Title: Director
2023-06-14